In the present study, we investigated the role of vasopressin in the development of quinpirole-induced hyperdipsia in the rat. We report that: (1), an acute intraperitoneal (i.p.) injection of 0.56 mg/kg of quinpirole increased plasma vasopressin (radioimmunoassay) at 15 min but not at 30 or 120 min; (2), nine daily injections of quinpirole (0.56 mg/kg, i.p.) progressively increased water intake and diuresis for a period of several hours after each treatment; (3), quinpirole hyperdipsia was associated with apparently normal levels of vasopressin (which might be considered inappropriately high in the presence of excessive drinking); (4), quinpirole reduced vasopressin and oxytocin, but not angiotensin, immunoreactivity in the supraoptic nucl...
Studies were carried out in the rat to investigate whether serotonin (5-HT) is involved in the regul...
The effects of the mixed dopamine D2/D3 agonist, quinpirole and antagonist, raclopride on ethanol co...
Abstract: Quinpirole (QNP) is a D2-like dopamine (DA) receptor agonist with some selectivity for D3 ...
Dopamine D2 receptor hyperactivity has been implicated in the development of psychogenic polydipsia ...
RATIONALE Dopamine D2 receptor hyperactivity has been implicated in the development of psychogeni...
Repeated administration of the dopamine D2/D3 agonist quinpirole (QNP) progressively increases non-r...
The hypothesis that the combined activation of D-1 and D-2 dopaminergic receptors is instrumental in...
Rationale Dopaminergic D2/D3 agonist quinpirole (QNP) elicits nonregulatory drinking in rats, a mode...
We have previously reported that repeated administrations of quinpirole, a D2/D3 dopamine receptor a...
We have previously reported that in rats given the choice between operant and free access to water (...
Rationale: Polydipsia is a severe complication of long-term schizophrenia and, despite its unknown p...
Rationale: In rats, quinpirole, a dopaminergic D2/D3 receptor agonist, elicits both hyperdipsia and ...
Rationale: The biological underpinnings of schizophrenic polydipsia are poorly understood. Objective...
RATIONALE: Quinpirole (QNP), a D2/D3 dopaminergic receptor agonist, was found to elicit an apparentl...
The discriminative stimulus effects of dopamine (DA) D3/D2 receptor agonists are thought to be media...
Studies were carried out in the rat to investigate whether serotonin (5-HT) is involved in the regul...
The effects of the mixed dopamine D2/D3 agonist, quinpirole and antagonist, raclopride on ethanol co...
Abstract: Quinpirole (QNP) is a D2-like dopamine (DA) receptor agonist with some selectivity for D3 ...
Dopamine D2 receptor hyperactivity has been implicated in the development of psychogenic polydipsia ...
RATIONALE Dopamine D2 receptor hyperactivity has been implicated in the development of psychogeni...
Repeated administration of the dopamine D2/D3 agonist quinpirole (QNP) progressively increases non-r...
The hypothesis that the combined activation of D-1 and D-2 dopaminergic receptors is instrumental in...
Rationale Dopaminergic D2/D3 agonist quinpirole (QNP) elicits nonregulatory drinking in rats, a mode...
We have previously reported that repeated administrations of quinpirole, a D2/D3 dopamine receptor a...
We have previously reported that in rats given the choice between operant and free access to water (...
Rationale: Polydipsia is a severe complication of long-term schizophrenia and, despite its unknown p...
Rationale: In rats, quinpirole, a dopaminergic D2/D3 receptor agonist, elicits both hyperdipsia and ...
Rationale: The biological underpinnings of schizophrenic polydipsia are poorly understood. Objective...
RATIONALE: Quinpirole (QNP), a D2/D3 dopaminergic receptor agonist, was found to elicit an apparentl...
The discriminative stimulus effects of dopamine (DA) D3/D2 receptor agonists are thought to be media...
Studies were carried out in the rat to investigate whether serotonin (5-HT) is involved in the regul...
The effects of the mixed dopamine D2/D3 agonist, quinpirole and antagonist, raclopride on ethanol co...
Abstract: Quinpirole (QNP) is a D2-like dopamine (DA) receptor agonist with some selectivity for D3 ...